3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
4
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
117
Triple Negative Breast Neoplasms
45
Neoplasm Metastasis
11
Pancreatic Neoplasms
8
Inflammatory Breast Neoplasms
7
Breast Neoplasms, Male
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Ovarian Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
4
Neoplasms
4
Lung Neoplasms
4
Carcinoma, Ductal, Breast
4
Sarcoma
3
Prostatic Neoplasms
3
Lymphoma, Non-Hodgkin
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Hodgkin Disease
2
Esophageal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Advanced Breast Cancer
2
Thrombocytosis
1
Stages II-III Breast Cancer
1
Primary Myelofibrosis
1
Interventions
tremelimumab
1
pembrolizumab
1
nilotinib
1
durvalumab
1
Trastuzumab
1
Psychiatric Rehabilitation
1
Paclitaxel
1
Oxaliplatin
1
Methods
1
Leucovorin
1
Laparoscopy
1
Gemcitabine
1
Fluorouracil
1
Electrocardiography
1
Early Intervention, Educational
1
EC regimen
1
Cisplatin
1
Carboplatin
1
CP protocol
1
Behavior Therapy
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Albumin-Bound Paclitaxel
×
Breast
×
Clear all
NCT03304210
2023-11-07
PIPAC-nabpac
University Hospital, Ghent
Phase 1
Completed
20 enrolled
16 charts